Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Januar 2024

Biotek-snakken — Januar 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
110 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #93

    Ja det har været nogle gode dage...

    1 Reply Last reply
    0
    • P Offline
      P Offline
      ProinvestorNEWS
      wrote on sidst redigeret af
      #94

      Video - Steg 220% på kun 3 dage - og jeg har aktien (Evaxion)!
      https://www.proinvestor.com/boards/118268

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #95

        Calliditas: Vera Therapeutics has released interesting additional 2b results

        Just a moment...

        favicon

        (www.redeye.se)

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #96

          "Exciting news as our new patent for TARPEYO now has been officially issued. This new patent, which provides protection until 2043, significantly strengthens TARPEYO’s product protection, further improving its unique value proposition. We are looking forward to continuing to expand our franchise IP protection in other territories."

          Link Preview Image
          Calliditas Receives Notice of Allowance for United States Patent Application Covering TARPEYO® - Calliditas Therapeutics AB | Renee Aguiar-Lucander

          Exciting news as our new patent for TARPEYO now has been officially issued. This new patent, which provides protection until 2043, significantly strengthens TARPEYO’s product protection, further improving its unique value proposition. We are looking forward to continuing to expand our franchise IP protection in other territories. https://lnkd.in/dbqhAd_W

          favicon

          LinkedIn (www.linkedin.com)

          1 Reply Last reply
          0
          • F Offline
            F Offline
            Fandel
            wrote on sidst redigeret af
            #97

            Godmorgen...

            1 Reply Last reply
            0
            • F Offline
              F Offline
              Fandel
              wrote on sidst redigeret af
              #98

              Godmorgen...

              1 Reply Last reply
              0
              • L Offline
                L Offline
                LP90
                wrote on sidst redigeret af
                #99

                Godmorgen 🙂

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #100

                  Gode nyheder fra alligator bio. https://alligatorbioscience.se/en/news/alligator-bioscience-announces-positive-mitazalimab-optimize-1-phase-2-results-meeting-primary-endpoint-and-demonstrating-clinically-relevant-survival-benefits-in-1st-line-pancreatic-cancer/

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #101

                    Alligator Bio har succes med deres CD40 monoclonale antistof Mitazalimab, så lad os håbe Genmab kan toppe den:

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #102

                      Link Preview Image
                      Alligator Bioscience Announces Positive Mitazalimab OPTIMIZE-1 Phase 2 Results Meeting Primary Endpoint and Demonstrating Clinically Relevant Survival Benefits in 1st Line Pancreatic Cancer – Alligator Bioscience

                      Top-line readout demonstrates Objective Response Rate of 40.4%, meeting primary endpoint and confirming the benefit of mitazalimab in combin ...

                      favicon

                      (alligatorbioscience.se)

                      1 Reply Last reply
                      0
                      • K Offline
                        K Offline
                        Kjølstad
                        wrote on sidst redigeret af
                        #103

                        Nogen der ved, hvad der sker i IRLAB AB for tiden. Den sidste måned er den steget med 100%? (Er gået ind i dag med en lille slat spillemønter) 🙂

                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          Kjølstad
                          wrote on sidst redigeret af
                          #104

                          PS: De er ved at afslutte et fase II-forsøg og har en aftale med FDA om et møde for opsætning af fase III-forsøg https://irlab.se/newsroom/pressrelease-archive/, men det i sig selv er vel ikke tilstrækkeligt til så stor en stigning?

                          1 Reply Last reply
                          0
                          • O Offline
                            O Offline
                            oge
                            wrote on sidst redigeret af
                            #105

                            Iterum? Nå en kan jo ikke vinde hver gang?

                            1 Reply Last reply
                            0
                            • O Offline
                              O Offline
                              oge
                              wrote on sidst redigeret af
                              #106

                              Hvor "dum" kan man være, det går jo stygende der i Iterum!

                              1 Reply Last reply
                              0
                              • O Offline
                                O Offline
                                oge
                                wrote on sidst redigeret af
                                #107

                                Ja, ja jeg har da stadig 33 stk tilbage -

                                1 Reply Last reply
                                0
                                • O Offline
                                  O Offline
                                  oge
                                  wrote on sidst redigeret af
                                  #108

                                  Og nu er de over 3? et eller andet (mener det er $)? Jow, øeeee er jo slet ikke med. Hvad laver jeg her!

                                  1 Reply Last reply
                                  0
                                  • exitnuE Offline
                                    exitnuE Offline
                                    exitnu
                                    wrote on sidst redigeret af
                                    #109

                                    Calliditas Therapeutics:
                                    Jefferies höjer riktkursen för Calliditas till 57 dollar per depåbevis (55), upprepar köp

                                    1 Reply Last reply
                                    0
                                    • exitnuE Offline
                                      exitnuE Offline
                                      exitnu
                                      wrote on sidst redigeret af
                                      #110

                                      Per d.d.: $22,29 ...

                                      1 Reply Last reply
                                      0
                                      • F Offline
                                        F Offline
                                        Fandel
                                        wrote on sidst redigeret af
                                        #111

                                        Godmorgen...

                                        1 Reply Last reply
                                        0

                                        Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                        Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                        With your input, this post could be even better 💗

                                        Tilmeld Log ind
                                        Svar
                                        • Svar som emne
                                        Login for at svare
                                        • Ældste til nyeste
                                        • Nyeste til ældste
                                        • Most Votes


                                        • Log ind

                                        • Har du ikke en konto? Tilmeld

                                        • Login or register to search.
                                        Powered by NodeBB Contributors
                                        • First post
                                          Last post
                                        0
                                        • Kategorier
                                        • Seneste
                                        • Etiketter
                                        • Populære
                                        • Verden
                                        • Bruger
                                        • Grupper